Key statistics
On Friday, Rigel Pharmaceuticals Inc (RIGL:NSQ) closed at 34.32, -34.30% below its 52-week high of 52.24, set on Nov 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 34.22 |
|---|---|
| High | 35.37 |
| Low | 34.22 |
| Bid | 33.03 |
| Offer | 34.98 |
| Previous close | 34.22 |
| Average volume | 268.69k |
|---|---|
| Shares outstanding | 18.15m |
| Free float | 17.69m |
| P/E (TTM) | 5.56 |
| Market cap | 622.95m USD |
| EPS (TTM) | 6.17 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Rigel Appoints Michael P. Miller to the Board of Directors
- Rigel Provides Business Update and 2026 Outlook
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
- Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
More ▼
